Your browser doesn't support javascript.
loading
High prevalence of insulin resistance among Brazilian chronic hepatitis C patients
Villar, Livia Melo; Caldas, Gabriela Cardoso; Scalioni, Leticia de Paula; Miguel, Juliana Custódio; Silva, Elisangela Ferreira da; Marques, Vanessa Alves; Villela-Nogueira, Cristiane Alves; Lewis-Ximenez, Lia Laura; Lampe, Elisabeth.
  • Villar, Livia Melo; Instituto Oswaldo Cruz. Laboratório de Hepatite Viral. Rio de Janeiro. BR
  • Caldas, Gabriela Cardoso; Instituto Oswaldo Cruz. Laboratório de Hepatite Viral. Rio de Janeiro. BR
  • Scalioni, Leticia de Paula; Instituto Oswaldo Cruz. Laboratório de Hepatite Viral. Rio de Janeiro. BR
  • Miguel, Juliana Custódio; Instituto Oswaldo Cruz. Laboratório de Hepatite Viral. Rio de Janeiro. BR
  • Silva, Elisangela Ferreira da; Instituto Oswaldo Cruz. Laboratório de Hepatite Viral. Rio de Janeiro. BR
  • Marques, Vanessa Alves; Instituto Oswaldo Cruz. Laboratório de Hepatite Viral. Rio de Janeiro. BR
  • Villela-Nogueira, Cristiane Alves; Universidade Federal do Rio de Janeiro. Hospital Universitário Clementino Fraga Filho (HUCFF). Departamento de Clínica Médica. Rio de Janeiro. BR
  • Lewis-Ximenez, Lia Laura; Instituto Oswaldo Cruz. Laboratório de Hepatite Viral. Rio de Janeiro. BR
  • Lampe, Elisabeth; Instituto Oswaldo Cruz. Laboratório de Hepatite Viral. Rio de Janeiro. BR
Arch. endocrinol. metab. (Online) ; 61(6): 628-632, Dec. 2017. tab
Article in English | LILACS | ID: biblio-1038487
ABSTRACT
ABSTRACT

Objective:

This study aims to estimate the prevalence of insulin resistance (IR) among chronic hepatitis C (CHC) patients and their related laboratory and demographic data. Subjects and

methods:

In this study, non-diabetic CHC patients referred to Viral Hepatitis Ambulatories from Rio de Janeiro (Brazil) donated blood samples. Insulin was measured using a chemiluminescence immunoassay. IR was determined by HOMA-IR, where HOMA-IR > 2 was defined as IR.

Results:

A total of 214 CHC patients were recruited (123 females aged 53.6 years ± 10.9 years). IR was present in 133 patients (62.1%) and was associated in bivariate analysis to higher mean values of age (p = 0.040), triglycerides (p = 0.032), glucose (p = 0.000), insulin (p = 0.000), waist circumference (p = 0.001), and body mass index (p = 0.007); however, none of these variables were significant in the multivariate analysis.

Conclusions:

The high prevalence of IR was observed among CHC patients, and there was no difference in clinical or laboratory parameters when both groups were compared in the multivariate analysis. This high IR prevalence could lead to a high risk for development of cardiovascular disease and metabolic disorders.
Subject(s)


Full text: Available Index: LILACS (Americas) Main subject: Insulin Resistance / Hepatitis C, Chronic Type of study: Prevalence study / Risk factors Limits: Female / Humans / Male Country/Region as subject: South America / Brazil Language: English Journal: Arch. endocrinol. metab. (Online) Journal subject: Endocrinology / Metabolism Year: 2017 Type: Article Affiliation country: Brazil Institution/Affiliation country: Instituto Oswaldo Cruz/BR / Universidade Federal do Rio de Janeiro/BR

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Index: LILACS (Americas) Main subject: Insulin Resistance / Hepatitis C, Chronic Type of study: Prevalence study / Risk factors Limits: Female / Humans / Male Country/Region as subject: South America / Brazil Language: English Journal: Arch. endocrinol. metab. (Online) Journal subject: Endocrinology / Metabolism Year: 2017 Type: Article Affiliation country: Brazil Institution/Affiliation country: Instituto Oswaldo Cruz/BR / Universidade Federal do Rio de Janeiro/BR